To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Interventional Cardiology Devices Market size was valued at USD 12.91 billion in 2019 and is poised to grow from USD 13.85 billion in 2023 to USD 24.34 billion by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

interventional cardiology devices market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Abbott', 'Boston Scientific Corporation', 'Medtronic', 'Edward Lifesciences Corporation', 'iVascular', 'Terumo Corporation', 'B. BarunMelsungen', 'BIOTRONIK SE & Co. KG', 'Biosensors International Group', 'Cardinal Health'

Consumption of saturated fats, excessive salt, alcohol consumption, and smoking are all poor lifestyle practises that significantly raise the risk of coronary artery disease, which is expected to accelerate of the interventional cardiology devices market. Furthermore, high tobacco consumption and a lack of exercise motivate market growth. Furthermore, physical inactivity can increase the risk of obesity and coronary artery disease.

Obesity is increasing the prevalence of cardiovascular disease. Furthermore, the incidence of coronary artery disease has increased as a result of changing lifestyles characterised by smoking, heavy alcohol consumption, and inactivity. With the use of interventional cardiology instruments, cardiologists can perform treatments quickly and without causing complications.

North America is expected to lead the interventional cardiology devices market throughout the forecast period due to the influence of advanced healthcare infrastructure, supportive government product development initiatives, and high patient awareness levels. According to the American Heart Association, by 2035, approximately 45% of the US population will be affected by heart disease as a result of factors such as high obesity, high smoking, and unhealthy lifestyles, which can cause a heart attack and other related issues. In addition, 1.5 million Americans are treated for diabetes each year in the United States alone. Incidence of diabetes is increasing primarily due to an increase in the geriatric population; it is guesstimated that 25% of all geriatric individuals (aged 60 and above) in the United States have diabetes.

Feedback From Our Clients

Global Interventional Cardiology Devices Market

Product ID: SQMIG35A2171